Hido Technologies is dedicated to enhancing home care through its AI-powered medication adherence platform, HiDO. The platform aims to reduce hospitalizations and emergency room visits by up to 78% among chronic care patients, promoting health equity and independence at home. HiDO offers services such as AI behavioral monitoring, real-time population health management, and direct-to-patient trials, targeting the over 150 million Americans living with chronic conditions.
Hido Technologies has made significant strides in improving patient outcomes and reducing healthcare costs. By leveraging advanced AI to eliminate medication errors and facilitate behavioral modification, the company has positioned itself as a leader in home health care innovation. The platform's ability to recruit and retain diverse patient populations for clinical trials further underscores its impact on the healthcare industry.
